TIBER CREEK GROUP for AMGEN INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 469 Affordable and Safe Prescription Drug Importation Act, H.R. 1245 Affordable and Safe Prescription Drug Importation Act, issues related to biosimilars and biosimilars coding. S 934 - FDARA, HR1409 - FDRA, S1348 - SPIKE Act of 2017. S.1519, the National Defense Authorization Act for 2018, Sec 706, Modification of cost-sharing requirements for the TRICARE Pharmacy Benefits Program. S 1827, The Keep Kids Insurance Dependable and Secure (KIDS) Act of 2017. Issues relating to reimbursement within the Hospital Outpatient Prospective Payment System
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JAMES HEIMBACH | — |
| JONATHON JONES | — |
| LINDSEY LEDWIN | — |
Medicare/Medicaid MMM
Medicare Part B reimbursement and coding, issues related to pharmaceutical pricing and transparency.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JAMES HEIMBACH | — |
| JONATHON JONES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.